Efficacy of the use of mefenamic acid combined with standard medical care vs. standard medical care alone for the treatment of COVID‑19: A randomized double‑blind placebo‑controlled trial.
Guzman-Esquivel J, Galvan-Salazar HR, Guzman-Solorzano HP, Cuevas-Velazquez AC, Guzman-Solorzano JA, Mokay-Ramirez KA, Paz-Michel BA, Murillo-Zamora E, Delgado-Enciso J, Melnikov V, Delgado-Enciso OG, Rodriguez-Sanchez IP, Martinez-Fierro ML, Rojas-Larios F, Walle-Guillen M, Cardenas-Aguilar CB, Beas-Guzman O, Chaviano-Conesa D, Garcia-Garcia HS, Delgado-Enciso I.
Guzman-Esquivel J, et al. Among authors: melnikov v.
Int J Mol Med. 2022 Mar;49(3):29. doi: 10.3892/ijmm.2022.5084. Epub 2022 Jan 14.
Int J Mol Med. 2022.
PMID: 35029292
Clinical Trial.